penicillamine has been researched along with Bone Diseases, Metabolic in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence of osteopenia and osteoporosis in children with WD was found as 22." | 1.35 | Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy. ( Doneray, H; Ertekin, V; Selimoglu, MA; Yildirim, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selimoglu, MA | 1 |
| Ertekin, V | 1 |
| Doneray, H | 1 |
| Yildirim, M | 1 |
1 other study available for penicillamine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Chelating Agents; Child; Child, Preschool; Femal | 2008 |